Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


June 30, 2015 11:55 AM ET

Biotechnology

Company Overview of Eagle Pharmaceuticals Inc.

Company Overview

Eagle Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing injectable products primarily in the critical care and oncology areas in the United States. The company offers argatroban to treat heparin-induced thrombocytopenia; and Ryanodex injectable suspension for the treatment of malignant hyperthermia. It develops EP-3101, a bendamustine ready to dilute (RTD) liquid and EP-3102, a bendamustine short infusion time RTD liquid for the treatment of chronic lymphocytic leukemia and indolent non-Hodgkin's lymphoma;; and EP-4104, a dantrolene for the treatment of exertional heat stroke. The company also develops EP-5101 (pemetrexed) as RTD liquid, whi...

50 Tice Boulevard

Suite 315

Woodcliff Lake, NJ 07677

United States

Founded in 2007

30 Employees

Phone:

201-326-5300

Key Executives for Eagle Pharmaceuticals Inc.

Chief Executive Officer, President and Director
Age: 54
Total Annual Compensation: $449.6K
Chief Financial Officer
Age: 61
Total Annual Compensation: $265.9K
Chief Medical Officer and Head of Research & Development
Age: 55
Total Annual Compensation: $303.8K
Chief Scientific Officer
Age: 55
Total Annual Compensation: $352.4K
Compensation as of Fiscal Year 2014.

Eagle Pharmaceuticals Inc. Key Developments

Eagle Pharmaceuticals Inc. Presents at Jefferies 2015 Global Healthcare Conference, Jun-03-2015 04:30 PM

Eagle Pharmaceuticals Inc. Presents at Jefferies 2015 Global Healthcare Conference, Jun-03-2015 04:30 PM. Venue: The Grand Hyatt Hotel, New York, New York, United States. Speakers: David E. Riggs, Chief Financial Officer, Scott L. Tarriff, Chief Executive Officer, President and Director.

Eagle Pharmaceuticals Inc. Presents at William Blair’s 35th Annual Growth Stock Conference, Jun-09-2015 12:50 PM

Eagle Pharmaceuticals Inc. Presents at William Blair’s 35th Annual Growth Stock Conference, Jun-09-2015 12:50 PM. Venue: Four Seasons Hotel, Chicago, Illinois, United States. Speakers: David E. Riggs, Chief Financial Officer, Scott L. Tarriff, Chief Executive Officer, President and Director.

Eagle Pharmaceuticals, Inc. Submits New Drug Application for Ready-To-Use Bivalirudin to U.S. Food and Drug Administration

Eagle Pharmaceuticals Inc. has submitted a 505(b)(2) New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its novel ready-to-use bivalirudin product (RTU bivalirudin). This product is a stable liquid intravenous formulation of bivalirudin, the same active ingredient as in The Medicine company’s Angiomax (bivalirudin). U.S. sales of Angiomax were approximately $600 million for the twelve months ended December 31, 2014. This 505(b)(2) NDA requests FDA approval of Eagle’s RTU bivalirudin product for the treatment of patients: 1) undergoing percutaneous coronary intervention (PCI) with use of glycoprotein IIb/IIIa inhibitor, 2) undergoing PCI with, or at risk of, heparin-induced thrombocytopenia and thrombosis syndrome, and/or 3) with unstable angina undergoing percutaneous transluminal coronary angioplasty (PTCA). RTU bivalirudin is intended for use with aspirin.

Similar Private Companies By Industry

Company Name Region
AGY Therapeutics Inc. United States
Enobia Canada Limited Partnership United States
Amulet Pharmaceuticals, Inc. United States
Perosphere Inc. United States
NephRx Corporation United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Eagle Pharmaceuticals Inc., please visit www.eagleus.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.